Skip to main content

Drugs Made In America Acquisition II Corp.

corporate_fare Company Profile

Drugs Made In America Acquisition II Corp.

DMII·NASDAQ·Real Estate & Construction·CIK 0002040475

Drugs Made In America Acquisition II Corp. does not currently have significant business operations. The company's primary objective is to complete a business combination, such as a merger, share exchange, asset acquisition, share purchase, recapitalization, or reorganization, with one or more existing businesses. It specifically aims to identify and assess companies operating within the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was established in 2024 and is located in New York, New York.

Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 10 items for DMII at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 8/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for DMII spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • SPAC Proposes $600M Alpha AI Biotech Deal; Investor Adds $250K Convertible Funding
  • SPAC Flags Going Concern, Material Weakness, and 35% Discount Convertible Notes
  • SPAC DMII Posts $4.34M Net Income in Q1 2026, Reversing Prior Loss
  • Company Discloses Material Weakness in Internal Controls, Reaffirms Going Concern
  • DMII Formalizes CEO & CFO Compensation with Significant Equity Grants Amid Cash Flow Constraints

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
$4.19M
Op. Cash Flow
-$1.02M
Operating Income
-$488.38K
Cash & Equivalents
$223
Debt / Equity
0.00×
Shares Outstanding
13.7M sh
Source: 10-K · filed 2026-04-15 · accession 0001213900-26-044055

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 96,992 shares in DMII as of the October 30, 2026 settlement, a 12.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 24.1% of DMII volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)96,992 shares as of October 30, 2026
Change vs prior period▼ 12.8%
Days to cover1.00 at avg daily volume of 224,401
Daily short volume (FINRA facilities)24.1% of 137,673 shares on November 20, 2026
5-day average short volume6.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with D →
$10.23 -0.20% today
52-week range · as of 2026-11-18 $9.86 – $10.33
Market cap
$651.65M
Volume
486.9K (2.2× avg)
3-mo avg 221.4K
Live data · 2026-11-22 03:34 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DMII - Latest Insights

DMII
Nov 18, 2026, 11:08 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.25
Real-time Price: $10.23 info
Change: -$0.015 (-0.15%) info
Market Cap: $651.651M info
DMII
Aug 14, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $10.13
Real-time Price: $10.23 info
Change: +$0.100 (+0.99%) info
Market Cap: $651.651M info
DMII
May 14, 2026, 4:27 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $10.03
Real-time Price: $10.23 info
Change: +$0.200 (+2%) info
Market Cap: $651.651M info
DMII
May 14, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $10.03
Real-time Price: $10.23 info
Change: +$0.200 (+2%) info
Market Cap: $651.651M info
DMII
Apr 28, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.01
Real-time Price: $10.23 info
Change: +$0.220 (+2%) info
Market Cap: $651.651M info
DMII
Apr 15, 2026, 4:09 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $10.00
Real-time Price: $10.23 info
Change: +$0.230 (+2%) info
Market Cap: $651.651M info
DMII
Apr 03, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.99
Real-time Price: $10.23 info
Change: +$0.240 (+2%) info
Market Cap: $651.651M info
DMII
Mar 17, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.96
Real-time Price: $10.23 info
Change: +$0.270 (+3%) info
Market Cap: $651.651M info
DMII
Mar 06, 2026, 5:01 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.94
Real-time Price: $10.23 info
Change: +$0.290 (+3%) info
Market Cap: $651.651M info
DMII
Mar 06, 2026, 10:10 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.98
Real-time Price: $10.23 info
Change: +$0.250 (+3%) info
Market Cap: $651.651M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets